Small Split Doses of CD34+ Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy

Cumulative myelosuppression is the main limiting factor for administration of repeated cycles of chemotherapy. We present a case series of five pediatric patients with high-risk solid malignancies who received small split peripheral blood stem cells (PBSC) doses of less than 1 × 106/kg CD34+ cells o...

Full description

Saved in:
Bibliographic Details
Main Authors: Maxim Yankelevich, Sureyya Savasan, Igor Dolgopolov, Roland Chu, George Mentkevich
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2017/4184879
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849404101451841536
author Maxim Yankelevich
Sureyya Savasan
Igor Dolgopolov
Roland Chu
George Mentkevich
author_facet Maxim Yankelevich
Sureyya Savasan
Igor Dolgopolov
Roland Chu
George Mentkevich
author_sort Maxim Yankelevich
collection DOAJ
description Cumulative myelosuppression is the main limiting factor for administration of repeated cycles of chemotherapy. We present a case series of five pediatric patients with high-risk solid malignancies who received small split peripheral blood stem cells (PBSC) doses of less than 1 × 106/kg CD34+ cells obtained after a single leukapheresis procedure and given after repeated cycles of ICE (ifosfamide, carboplatin, and etoposide) chemotherapy. Mean duration to absolute neutrophil count (ANC) recovery to >1000/mm3 and platelet recovery to >50 × 103/mm3 was 17.1 and 24.3 days. Using split doses of PBSC prevented prolonged neutropenia after repeated cycles of submyeloablative chemotherapy.
format Article
id doaj-art-91c23196670a46acbb3616db07559d5e
institution Kabale University
issn 2090-6706
2090-6714
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Case Reports in Oncological Medicine
spelling doaj-art-91c23196670a46acbb3616db07559d5e2025-08-20T03:37:06ZengWileyCase Reports in Oncological Medicine2090-67062090-67142017-01-01201710.1155/2017/41848794184879Small Split Doses of CD34+ Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative ChemotherapyMaxim Yankelevich0Sureyya Savasan1Igor Dolgopolov2Roland Chu3George Mentkevich4Division of Hematology/Oncology, Department of Pediatrics, Children’s Hospital of Michigan, Wayne State University, 3901 Beaubien Street, Detroit, MI 48201, USADivision of Hematology/Oncology, Department of Pediatrics, Children’s Hospital of Michigan, Wayne State University, 3901 Beaubien Street, Detroit, MI 48201, USAInstitute for Pediatric Oncology, N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye Shosse, Moscow 115478, RussiaDivision of Hematology/Oncology, Department of Pediatrics, Children’s Hospital of Michigan, Wayne State University, 3901 Beaubien Street, Detroit, MI 48201, USAInstitute for Pediatric Oncology, N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye Shosse, Moscow 115478, RussiaCumulative myelosuppression is the main limiting factor for administration of repeated cycles of chemotherapy. We present a case series of five pediatric patients with high-risk solid malignancies who received small split peripheral blood stem cells (PBSC) doses of less than 1 × 106/kg CD34+ cells obtained after a single leukapheresis procedure and given after repeated cycles of ICE (ifosfamide, carboplatin, and etoposide) chemotherapy. Mean duration to absolute neutrophil count (ANC) recovery to >1000/mm3 and platelet recovery to >50 × 103/mm3 was 17.1 and 24.3 days. Using split doses of PBSC prevented prolonged neutropenia after repeated cycles of submyeloablative chemotherapy.http://dx.doi.org/10.1155/2017/4184879
spellingShingle Maxim Yankelevich
Sureyya Savasan
Igor Dolgopolov
Roland Chu
George Mentkevich
Small Split Doses of CD34+ Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy
Case Reports in Oncological Medicine
title Small Split Doses of CD34+ Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy
title_full Small Split Doses of CD34+ Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy
title_fullStr Small Split Doses of CD34+ Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy
title_full_unstemmed Small Split Doses of CD34+ Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy
title_short Small Split Doses of CD34+ Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy
title_sort small split doses of cd34 peripheral blood stem cells to support repeated cycles of nonmyeloablative chemotherapy
url http://dx.doi.org/10.1155/2017/4184879
work_keys_str_mv AT maximyankelevich smallsplitdosesofcd34peripheralbloodstemcellstosupportrepeatedcyclesofnonmyeloablativechemotherapy
AT sureyyasavasan smallsplitdosesofcd34peripheralbloodstemcellstosupportrepeatedcyclesofnonmyeloablativechemotherapy
AT igordolgopolov smallsplitdosesofcd34peripheralbloodstemcellstosupportrepeatedcyclesofnonmyeloablativechemotherapy
AT rolandchu smallsplitdosesofcd34peripheralbloodstemcellstosupportrepeatedcyclesofnonmyeloablativechemotherapy
AT georgementkevich smallsplitdosesofcd34peripheralbloodstemcellstosupportrepeatedcyclesofnonmyeloablativechemotherapy